what's the difference of tirzepatide and semaglutide Comparative safety side effects and tirzepatide: Implications for clinical decision-making in obesity management Tirzepatide vs Semaglutide Cost: Why

Consult your provider about moving to the next step in the dosage chart

Pharmacokinetic comparisons between diabetic individuals and healthy individuals have shown that tirzepatide delays gastric emptying, particularly after a single dose, and demonstrates a decrease in effectiveness or responsiveness with repeated once-weekly dosing, referred to as tachyphylaxis [44, 72]

For Zepbound's 10mg weekly dose, the average weight loss was 22.2 kg (48.9 lb), and for Zepbound's 15mg weekly dose average weight loss was 23.6 kg (52.0 lb) over 72 weeks

This review underscores the importance of comprehending GLP-1s cardiovascular impact in diabetes, especially considering its increasing use in patients, discussing both risk factor mitigation and direct cardiac and vascular effects, and exploring GLP-1s potential as a novel therapy for diabetic CVD